Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis

Antecedentes: La Artritis Reumatoide (AR) es una enfermedad autoinmune, caracterizada por un daño articular progresivo que limita la calidad de vida y años laborales de los pacientes, y un alto costo para los sistemas de salud. Aún se desconoce completamente su fisiopatología, sin embargo, se han re...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2024
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/42989
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/42989
Palabra clave:
Artritis reumatoide
Artritis reumatoide sistémica juvenil
Artritis Idiopática juvenil
Survivina
Biomarcadores
Rheumatoid arthritis
Juvenile Systemic Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Survivin
Biomarkers
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International
id EDOCUR2_df03497be6ec27b87f1561136040c657
oai_identifier_str oai:repository.urosario.edu.co:10336/42989
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.none.fl_str_mv Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
dc.title.TranslatedTitle.none.fl_str_mv Survivin levels and its clinical utility in rheumatoid arthritis/juvenile idiopathic arthritis: systematic review of the literature and meta-analysis
title Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
spellingShingle Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
Artritis reumatoide
Artritis reumatoide sistémica juvenil
Artritis Idiopática juvenil
Survivina
Biomarcadores
Rheumatoid arthritis
Juvenile Systemic Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Survivin
Biomarkers
title_short Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
title_full Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
title_fullStr Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
title_full_unstemmed Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
title_sort Niveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisis
dc.contributor.advisor.none.fl_str_mv Rojas Quintana, Manuel Eduardo
Acosta Ampudia, Yeny Yasbleidy
dc.contributor.gruplac.none.fl_str_mv Centro de Estudio de Enfermedades Autoinmunes - CREA
dc.subject.none.fl_str_mv Artritis reumatoide
Artritis reumatoide sistémica juvenil
Artritis Idiopática juvenil
Survivina
Biomarcadores
topic Artritis reumatoide
Artritis reumatoide sistémica juvenil
Artritis Idiopática juvenil
Survivina
Biomarcadores
Rheumatoid arthritis
Juvenile Systemic Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Survivin
Biomarkers
dc.subject.keyword.none.fl_str_mv Rheumatoid arthritis
Juvenile Systemic Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Survivin
Biomarkers
description Antecedentes: La Artritis Reumatoide (AR) es una enfermedad autoinmune, caracterizada por un daño articular progresivo que limita la calidad de vida y años laborales de los pacientes, y un alto costo para los sistemas de salud. Aún se desconoce completamente su fisiopatología, sin embargo, se han realizado estudios en busca de nuevos biomarcadores para su diagnóstico. La Survivina aparentemente está implicada en la fisiopatología de la enfermedad y es un potencial biomarcador en esta condición. Objetivos: Integrar la evidencia del papel de la proteína Survivina y su asociación con la AR y Artritis Idiopática Juvenil (AIJ), a través de una revisión sistemática de la literatura. Métodos de búsqueda: Se hicieron búsquedas en las siguientes bases de datos hasta abril de 2023: PubMed, EMBASE, y CINAHL. Criterios de selección: Se incluyeron todos los estudios observacionales analíticos y ensayos clínicos que incluían pacientes con AR o AIJ, y controles sanos, que evaluaran la presencia de Survivina en suero, plasma o líquido sinovial detectado por medio de ELISA o qPCR. Obtención y análisis de los datos: Dos investigadores revisaron y evaluaron de forma independiente la literatura para inclusión y riesgo de sesgo, se extrajeron los datos y verificaron su exactitud, se construyó la base de datos con las variables incluidas. Para la positividad de Survivina se usó la estimación de OR usando modelo de efectos aleatorios, y para el caso de los valores cuantitativos usamos la diferencia de medias estandarizadas (DME). Resultados principales: El meta-análisis incluyó siete estudios, 5 estudios incluyeron casos y controles (n: 3 para AR, y n: 2 AIJ) y 2 fueron estudios transversales (AR). Los pacientes con AR/AIJ tuvieron una mayor positividad para Survivina en suero en comparación con los controles (913/1738 [52,5%] frente a 245/2010 [ 12,1%]) con un OR 13,89 [IC 95%, 1,74- 110,89]). El análisis de DME confirmó que los pacientes con AR/AIJ presentan niveles más elevados de Survivina en comparación con los controles (DME = 2,05 [IC del 95 %: 0,55-3,56]). Respecto a líquido sinovial, estudios demostraron niveles elevados de Survivina en líquido sinovial en pacientes con AIJ y AR en comparación con controles, mediante ELISA, inmunohistoquímica, entre otras. Así mismo, diferentes estudios han reportado la correlación entre niveles elevados de Survivina, con tabaquismo y positividad de autoanticuerpos (FR y ACPAs). 12 Conclusiones: La Survivina es un potencial biomarcador para el diagnóstico de AR/AIJ. Estudios que evalúen si el biomarcador de artritis-especifico, así como su importancia en la actividad de la enfermedad y el pronóstico, son necesarios.
publishDate 2024
dc.date.accessioned.none.fl_str_mv 2024-07-10T14:29:24Z
dc.date.available.none.fl_str_mv 2024-07-10T14:29:24Z
dc.date.created.none.fl_str_mv 2024-06-10
dc.type.none.fl_str_mv bachelorThesis
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.document.none.fl_str_mv Trabajo de grado
dc.type.spa.none.fl_str_mv Trabajo de grado
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/42989
url https://repository.urosario.edu.co/handle/10336/42989
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.none.fl_str_mv Abierto (Texto Completo)
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
Abierto (Texto Completo)
http://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.extent.none.fl_str_mv 70 pp
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad del Rosario
Universidad CES. Facultad de Medicina
dc.publisher.department.none.fl_str_mv Escuela de Medicina y Ciencias de la Salud
dc.publisher.program.none.fl_str_mv Especialización en Epidemiología
publisher.none.fl_str_mv Universidad del Rosario
Universidad CES. Facultad de Medicina
institution Universidad del Rosario
dc.source.bibliographicCitation.none.fl_str_mv Smolen, Josef S; Aletaha, Daniel; McInnes, Iain B (2016) Rheumatoid arthritis. En: The Lancet. Vol. 388; No. 10055; pp. 2023 - 2038; Disponible en: 10.1016/S0140-6736(16)30173-8.
Finckh, Axel; Gilbert, Benoît; Hodkinson, Bridget; Bae, Sang-Cheol; Thomas, Ranjeny; Deane, Kevin D.; Alpizar-Rodriguez, Deshiré; Lauper, Kim (2022) Global epidemiology of rheumatoid arthritis. En: Nature Reviews Rheumatology. Disponible en: 10.1038/s41584-022-00827-y.
Birnbaum, Howard; Pike, Crystal; Kaufman, Rebecca; Maynchenko, Maryna; Kidolezi, Yohanne; Cifaldi, Mary (2010) Societal cost of rheumatoid arthritis patients in the US. En: Current Medical Research and Opinion. Vol. 26; No. 1; pp. 77 - 90; Disponible en: 10.1185/03007990903422307.
Joensuu, Jaana T.; Huoponen, Saara; Aaltonen, Kalle J.; Konttinen, Yrjö T.; Nordström, Dan; Blom, Marja (2015) The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review. En: PLOS ONE. Vol. 10; No. 3; pp. e0119683 - e0119683; Disponible en: 10.1371/journal.pone.0119683.
Zafari, Parisa; Rafiei, Alireza; Esmaeili, Seyed‐Alireza; Moonesi, Mohammadreza; Taghadosi, Mahdi (2019) Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. En: Journal of Cellular Physiology. Vol. 234; No. 12; pp. 21575 - 21587; Disponible en: 10.1002/jcp.28784.
Yamanishi, Yuji; Boyle, David L.; Rosengren, Sanna; Green, Douglas R.; Zvaifler, Nathan J.; Firestein, Gary S. (2002) Regional analysis of p53 mutations in rheumatoid arthritis synovium. En: Proceedings of the National Academy of Sciences. Vol. 99; No. 15; pp. 10025 - 10030; Disponible en: 10.1073/pnas.152333199.
Radu, Andrei-Flavius; Bungau, Simona Gabriela (2021) Management of Rheumatoid Arthritis: An Overview. En: Cells. Vol. 10; No. 11; pp. 2857 - 2857; Disponible en: 10.3390/cells10112857.
Moher, David; Liberati, Alessandro; Tetzlaff, Jennifer; Altman, Douglas G. (2010) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. En: International Journal of Surgery. Vol. 8; No. 5; pp. 336 - 341; Disponible en: 10.1016/j.ijsu.2010.02.007.
Kerkman, Priscilla F; Kempers, Ayla C; van der Voort, Ellen I H; van Oosterhout, Maikel; Huizinga, Tom W J; Toes, René E M; Scherer, Hans U (2016) Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies. En: Annals of the Rheumatic Diseases. Vol. 75; No. 12; pp. 2201 - 2207; Disponible en: 10.1136/annrheumdis-2015-208554.
Lin, Yen-Ju; Anzaghe, Martina; Schülke, Stefan (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. En: Cells. Vol. 9; No. 4; pp. 880 - 880; Disponible en: 10.3390/cells9040880.
Fernández-Ávila, Daniel G.; Rincón-Riaño, Diana N.; Bernal-Macías, Santiago; Gutiérrez Dávila, Juan M.; Rosselli, Diego (2019) Prevalencia de la artritis reumatoide en Colombia según información del Sistema Integral de Información de la Protección Social. En: Revista Colombiana de Reumatología. Vol. 26; No. 2; pp. 83 - 87; Disponible en: 10.1016/j.rcreu.2019.01.003.
Radwan‐Oczko, Małgorzata; Duś‐Ilnicka, Irena; Richards, Pamela; Thomsen, Anna Marie; Rasmussen, Claus (2019) Rheumatoid arthritis patients' oral health and disease activity. En: International Journal of Rheumatic Diseases. pp. 1756 - 185X.13590; Disponible en: 10.1111/1756-185X.13590.
Wegner, Natalia; Lundberg, Karin; Kinloch, Andrew; Fisher, Benjamin; Malmström, Vivianne; Feldmann, Marc; Venables, Patrick J. (2010) Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. En: Immunological Reviews. Vol. 233; No. 1; pp. 34 - 54; Disponible en: 10.1111/j.0105-2896.2009.00850.x.
Kurowska, Weronika; Kuca-Warnawin, Ewa H.; Radzikowska, Anna; Maśliński, Włodzimierz (2017) The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. En: Central European Journal of Immunology. Vol. 42; No. 4; pp. 390 - 398; Disponible en: 10.5114/ceji.2017.72807.
Gómez, Antonio (2011) Nuevos criterios de clasificación de artritis reumatoide. En: Reumatología Clínica. Vol. 6; pp. 33 - 37; Disponible en: 10.1016/j.reuma.2011.01.002.
Aletaha, D.; Neogi, T.; Silman, A. J.; Funovits, J.; Felson, D. T.; Bingham, C. O.; Birnbaum, N. S.; Burmester, G. R.; Bykerk, V. P.; Cohen, M. D.; Combe, B.; Costenbader, K. H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J. M.; Hobbs, K.; Huizinga, T. W.; Kavanaugh, A.; Kay, J.; Kvien, T. K.; Laing, T.; Mease, P.; Menard, H. A.; Moreland, L. W.; Naden, R. L.; Pincus, T.; Smolen, J. S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P. P.; Upchurch, K. S.; Vencovsky, J.; Wolfe, F.; Hawker, G. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. En: Annals of the Rheumatic Diseases. Vol. 69; No. 9; pp. 1580 - 1588; Disponible en: 10.1136/ard.2010.138461.
Khodashahi, Mandana; Saadati, Nayyereh; Sahebari, Maryam; Rezaieyazdi, Zahra; Rastgou, Neda (2020) Diagnostic Role of Survivin in Rheumatoid Arthritis: A Systematic Review. En: Current Rheumatology Reviews. Vol. 16; No. 4; pp. 267 - 279; Disponible en: 10.2174/1573397116666200116095039.
Page, Matthew J; McKenzie, Joanne E; Bossuyt, Patrick M; Boutron, Isabelle; Hoffmann, Tammy C; Mulrow, Cynthia D; Shamseer, Larissa; Tetzlaff, Jennifer M; Akl, Elie A; Brennan, Sue E; Chou, Roger; Glanville, Julie; Grimshaw, Jeremy M; Hróbjartsson, Asbjørn; Lalu, Manoj M; Li, Tianjing; Loder, Elizabeth W; Mayo-Wilson, Evan; McDonald, Steve; McGuinness, Luke A; Stewart, Lesley A; Thomas, James; Tricco, Andrea C; Welch, Vivian A; Whiting, Penny; Moher, David (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. En: BMJ. pp. n71 - n71; Disponible en: 10.1136/bmj.n71.
Sociedad Española de Reumatología., Alejandro; Pascual-Salcedo, Dora; Martín-Mola, Emilio (2000) Revista española de reumatología : órgano oficial de la Sociedad Española de Reumatología. En: Revista Española de Reumatología. Vol. 27; No. 6; pp. 247 - 249; La Sociedad; Disponible en: http://www.elsevier.es/es-revista-revista-espanola-reumatologia-29-articulo-artritis-reumatoide-11712.
Anaya, J. M.; Shoenfeld, Y.; Rojas-Villarraga, A.; Levy, R. A.; Cervera, R. (2013) Autoimmunity: From Bench to Bedside. Bogota: El Rosario University Press.; 9789587383669;
Anaya, Juan-Manuel (2014) The diagnosis and clinical significance of polyautoimmunity. En: Autoimmunity Reviews. Vol. 13; No. 4-5; pp. 423 - 426; Disponible en: 10.1016/j.autrev.2014.01.049.
Wang, Lifeng; Wang, Fu-Sheng; Gershwin, M. Eric (2015) Human autoimmune diseases: a comprehensive update. En: Journal of Internal Medicine. Vol. 278; No. 4; pp. 369 - 395; Disponible en: 10.1111/joim.12395.
Moroni, Luca; Bianchi, Ilaria; Lleo, Ana (2012) Geoepidemiology, gender and autoimmune disease. En: Autoimmunity Reviews. Vol. 11; No. 6-7; pp. A386 - A392; Disponible en: 10.1016/j.autrev.2011.11.012.
Anaya, Juan-Manuel (2010) The autoimmune tautology. En: Arthritis Research & Therapy. Vol. 12; No. 6; pp. 147 - 147; Disponible en: 10.1186/ar3175.
van der Woude, Diane; van der Helm-van Mil, Annette H.M. (2018) Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. En: Best Practice & Research Clinical Rheumatology. Vol. 32; No. 2; pp. 174 - 187; Disponible en: 10.1016/j.berh.2018.10.005.
Littlejohn, Emily A.; Monrad, Seetha U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. En: Primary Care: Clinics in Office Practice. Vol. 45; No. 2; pp. 237 - 255; Disponible en: 10.1016/j.pop.2018.02.010.
Sparks, Jeffrey A. (2019) Rheumatoid Arthritis. En: Annals of Internal Medicine. Vol. 170; No. 1; pp. ITC1 - ITC1; Disponible en: 10.7326/AITC201901010.
Burmester, Gerd R; Pope, Janet E (2017) Novel treatment strategies in rheumatoid arthritis. En: The Lancet. Vol. 389; No. 10086; pp. 2338 - 2348; Disponible en: 10.1016/S0140-6736(17)31491-5.
Ouzzani, Mourad; Hammady, Hossam; Fedorowicz, Zbys; Elmagarmid, Ahmed (2016) Rayyan—a web and mobile app for systematic reviews. En: Systematic Reviews. Vol. 5; No. 1; pp. 210 - 210; Disponible en: 10.1186/s13643-016-0384-4.
Petty, Ross E; Southwood, Taunton R; Manners, Prudence; Baum, John; Glass, David N; Goldenberg, Jose; He, Xiaohu; Maldonado-Cocco, Jose; Orozco-Alcala, Javier; Prieur, Anne-Marie; Suarez-Almazor, Maria E; Woo, Patricia; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. En: The Journal of rheumatology. Vol. 31; No. 2; pp. 390 - 2;
Sah, Nand K.; Seniya, Chandrabhan (2015) Survivin splice variants and their diagnostic significance. En: Tumor Biology. Vol. 36; No. 9; pp. 6623 - 6631; Disponible en: 10.1007/s13277-015-3865-5.
Mahotka, C; Wenzel, M; Springer, E; Gabbert, H E; Gerharz, C D (1999) Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. En: Cancer research. Vol. 59; No. 24; pp. 6097 - 102;
Badran, Adel; Yoshida, Akira; Ishikawa, Keiko; Goi, Takanori; Yamaguchi, Akio; Ueda, Takanori; Inuzuka, Manabu (2004) Identification of a novel splice variant of the human anti-apoptopsis gene survivin. En: Biochemical and Biophysical Research Communications. Vol. 314; No. 3; pp. 902 - 907; Disponible en: 10.1016/j.bbrc.2003.12.178.
Caldas, Hugo; Honsey, Laura E; Altura, Rachel A (2005) Survivin 2α: a novel Survivin splice variant expressed in human malignancies. En: Molecular Cancer. Vol. 4; No. 1; pp. 11 - 11; Disponible en: 10.1186/1476-4598-4-11.
Scherer, Hans Ulrich; Häupl, Thomas; Burmester, Gerd R. (2020) The etiology of rheumatoid arthritis. En: Journal of Autoimmunity. Vol. 110; pp. 102400 - 102400; Disponible en: 10.1016/j.jaut.2019.102400.
Andersen, Mads Hald; Svane, Inge Marie; Becker, Jürgen C.; Straten, Per thor (2007) The Universal Character of the Tumor-Associated Antigen Survivin. En: Clinical Cancer Research. Vol. 13; No. 20; pp. 5991 - 5994; Disponible en: 10.1158/1078-0432.CCR-07-0686.
Arnett, Frank C.; Edworthy, Steven M.; Bloch, Daniel A.; Mcshane, Dennis J.; Fries, James F.; Cooper, Norman S.; Healey, Louis A.; Kaplan, Stephen R.; Liang, Matthew H.; Luthra, Harvinder S.; Medsger, Thomas A.; Mitchell, Donald M.; Neustadt, David H.; Pinals, Robert S.; Schaller, Jane G.; Sharp, John T.; Wilder, Ronald L.; Hunder, Gene G. (1988) The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. En: Arthritis & Rheumatism. Vol. 31; No. 3; pp. 315 - 324; Disponible en: 10.1002/art.1780310302.
Moola S; Munn Z; Tufanaru C; Aromataris E; Sears K; Sfetcu R; Currie M; Qureshi R; Mattis P; Lisy K; Mu P-F (2020) Chapter 7: Systematic reviews of etiology and risk. En: JBI Manual for Evidence Synthesis.: JBI; Disponible en: 10.46658/JBIMES-20-08.
Galeotti, L; Adrian, K; Berg, S; Tarkowski, A; Bokarewa, M (2008) Circulating survivin indicates severe course of juvenile idiopathic arthritis. En: Clinical and experimental rheumatology. Vol. 26; No. 2; pp. 373 - 8;
Chun-Lai, Too; Murad, Shahnaz; Erlandsson, Malin C.; Hussein, Heselynn; Sulaiman, Wahinuddin; Dhaliwal, Jasbir S.; Bokarewa, Maria I. (2015) Recognizing Rheumatoid Arthritis: Oncoprotein Survivin Opens New Possibilities. En: Medicine. Vol. 94; No. 4; pp. e468 - e468; Disponible en: 10.1097/MD.0000000000000468.
Baraka, Eman Abdel Alim; El Din, Mounir Serag; El Shambky, Ahmed; Fouad, Nehad A.; Abdelkader, Mona Abdullah (2019) Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity. En: Egyptian Rheumatology and Rehabilitation. Vol. 46; No. 4; pp. 221 - 228; Disponible en: 10.4103/err.err_40_19.
Lipinska, Joanna; Kaszkowiak, Marcin; Malachowska, Beata; Swidrowska-Jaros, Joanna; Smolewska, Elzbieta (2021) Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value—a single-center study. En: Arthritis Research & Therapy. Vol. 23; No. 1; pp. 40 - 40; Disponible en: 10.1186/s13075-021-02424-y.
Radwan, Abdullah; Allam, Ahmed (2021) Clinical significance of serum survivin in rheumatoid arthritis patients: Relation to disease activity, functional status and radiological damage. En: The Egyptian Rheumatologist. Vol. 43; No. 2; pp. 109 - 113; Disponible en: 10.1016/j.ejr.2020.12.008.
Bokarewa, Maria; Lindblad, Sofia; Bokarew, Dmitriy; Tarkowski, Andrej (2005) Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. En: Arthritis research & therapy. Vol. 7; No. 2; pp. R349 - 58; Disponible en: 10.1186/ar1498.
Svensson, Björn; Hafström, Ingiäld; Erlandsson, Malin C; Forslind, Kristina; Bokarewa, Maria I (2014) Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study. En: Arthritis Research & Therapy. Vol. 16; No. 1; pp. R12 - R12; Disponible en: 10.1186/ar4438.
Li, Fengzhi; Ling, Xiang (2006) Survivin study: An update of “What is the next wave?”. En: Journal of Cellular Physiology. Vol. 208; No. 3; pp. 476 - 486; Disponible en: 10.1002/jcp.20634.
Prasad, Peeyush; Verma, Sneha; Surbhi; Ganguly, Nirmal Kumar; Chaturvedi, Ved; Mittal, Shivani Arora (2023) Rheumatoid arthritis: advances in treatment strategies. En: Molecular and Cellular Biochemistry. Vol. 478; No. 1; pp. 69 - 88; Disponible en: 10.1007/s11010-022-04492-3.
Perumal, Narayanan B.; Kaplan, Mark H. (2011) Regulating Il9 transcription in T helper cells. En: Trends in Immunology. Vol. 32; No. 4; pp. 146 - 150; Disponible en: 10.1016/j.it.2011.01.006.
Isgren, Anniella; Forslind, Kristina; Erlandsson, Malin; Axelsson, Carl; Andersson, Sofia; Lund, Anneli; Bokarewa, Maria (2012) High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis. En: Seminars in Arthritis and Rheumatism. Vol. 41; No. 5; pp. 652 - 657; Disponible en: 10.1016/j.semarthrit.2011.08.005.
Erlandsson, Malin C.; Turkkila, Minna; Pullerits, Rille; Bokarewa, Maria I. (2018) Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA—Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA. En: Frontiers in Medicine. Vol. 5; Disponible en: 10.3389/fmed.2018.00219.
Svensson, Björn; Hafström, Ingiäld; Forslind, Kristina; Albertsson, Kristina; Tarkowski, Andrej; Bokarewa, Maria (2010) Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis. En: Annals of Medicine. Vol. 42; No. 1; pp. 45 - 54; Disponible en: 10.3109/07853890903376280.
van der Heijde, D M; van Leeuwen, M A; van Riel, P L; van de Putte, L B (1995) Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). En: The Journal of rheumatology. Vol. 22; No. 9; pp. 1792 - 6;
Chaudhary, Ajay K.; Yadav, Neelu; Bhat, Tariq A.; O’Malley, Jordan; Kumar, Sandeep; Chandra, Dhyan (2016) A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapy. En: Drug Discovery Today. Vol. 21; No. 1; pp. 38 - 47; Disponible en: 10.1016/j.drudis.2015.07.014.
Dharmapatni, Anak ASSK; Smith, Malcolm D; Findlay, David M; Holding, Christopher A; Evdokiou, Andreas; Ahern, Michael J; Weedon, Helen; Chen, Paul; Screaton, Gavin; Xu, Xiao N; Haynes, David R (2009) Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. En: Arthritis Research & Therapy. Vol. 11; No. 1; pp. R13 - R13; Disponible en: 10.1186/ar2603.
Ahn, Joong Kyong; Oh, Ji-Min; Lee, Jaejoon; Bae, Eun-Kyung; Ahn, Kwang-Sung; Cha, Hoon-Suk; Koh, Eun-Mi (2010) Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. En: Inflammation. Vol. 33; No. 6; pp. 381 - 8; Disponible en: 10.1007/s10753-010-9196-1.
Prahalad, Sampath; Glass, David N (2002) Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?. En: Arthritis Research. Vol. 4; No. Suppl 3; pp. 303 - 303; Disponible en: 10.1186/ar594.
Chang, Jang-Yang; Cheung, Chun Hei Antonio; Huang, Chien-Chang; Tsai, Fang-Ying; Lee, Jane Ying-Chieh; Cheng, Siao Muk; Chang, Yung-Chieh; Huang, Yi-Chun; Chen, Shang-Hung (2013) Survivin. En: OncoTargets and Therapy. pp. 1453 - 1453; Disponible en: 10.2147/OTT.S33374.
Li, Fengzhi (2003) Survivin study: What is the next wave?. En: Journal of Cellular Physiology. Vol. 197; No. 1; pp. 8 - 29; Disponible en: 10.1002/jcp.10327.
Gravina, G.; Wasén, C.; Garcia-Bonete, M.J.; Turkkila, M.; Erlandsson, M.C.; Töyrä Silfverswärd, S.; Brisslert, M.; Pullerits, R.; Andersson, K.M.; Katona, G.; Bokarewa, M.I. (2017) Survivin in autoimmune diseases. En: Autoimmunity Reviews. Vol. 16; No. 8; pp. 845 - 855; Disponible en: 10.1016/j.autrev.2017.05.016.
Kitagawa, Mayumi; Lee, Sang Hyun (2015) The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis. En: Frontiers in Cell and Developmental Biology. Vol. 3; Disponible en: 10.3389/fcell.2015.00014.
Eckelman, Brendan P; Salvesen, Guy S; Scott, Fiona L (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. En: EMBO reports. Vol. 7; No. 10; pp. 988 - 994; Disponible en: 10.1038/sj.embor.7400795.
Araya, Luam E.; Soni, Ishankumar V.; Hardy, Jeanne A.; Julien, Olivier (2021) Deorphanizing Caspase-3 and Caspase-9 Substrates In and Out of Apoptosis with Deep Substrate Profiling. En: ACS Chemical Biology. Vol. 16; No. 11; pp. 2280 - 2296; Disponible en: 10.1021/acschembio.1c00456.
Altznauer, Frank; Martinelli, Sibylla; Yousefi, Shida; Thürig, Christine; Schmid, Inès; Conway, Edward M.; Schöni, Martin H.; Vogt, Peter; Mueller, Christoph; Fey, Martin F.; Zangemeister-Wittke, Uwe; Simon, Hans-Uwe (2004) Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils. En: The Journal of Experimental Medicine. Vol. 199; No. 10; pp. 1343 - 1354; Disponible en: 10.1084/jem.20032033.
Xing, Zheng; Conway, Edward M.; Kang, Chulho; Winoto, Astar (2004) Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis. En: The Journal of Experimental Medicine. Vol. 199; No. 1; pp. 69 - 80; Disponible en: 10.1084/jem.20031588.
Bokarewa, Maria; Brink, Mikael; Erlandsson, Malin; Rantapää Dahlqvist, Solbritt (2014) Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study. En: Arthritis Research & Therapy. Vol. 16; No. 1; pp. R45 - R45; Disponible en: 10.1186/ar4474.
Levitsky, Adrian; Erlandsson, Malin C.; van Vollenhoven, Ronald F.; Bokarewa, Maria I. (2015) Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. En: BMC Medicine. Vol. 13; No. 1; pp. 247 - 247; Disponible en: 10.1186/s12916-015-0485-2.
Shi, Rui; Chen, Muzhi; Litifu, Bahaerguli; Zhaorigetu (2018) Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis. En: Modern Rheumatology. Vol. 28; No. 1; pp. 126 - 132; Disponible en: 10.1080/14397595.2017.1317384.
Figus, Fabiana Assunta; Piga, Matteo; Azzolin, Irene; McConnell, Rebecca; Iagnocco, Annamaria (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. En: Autoimmunity Reviews. Vol. 20; No. 4; pp. 102776 - 102776; Disponible en: 10.1016/j.autrev.2021.102776.
Pahlavan, Yasamin; kahroba, Houman; Samadi, Nasser; Karimi, Abbas; Ansarin, Khalil; Khabbazi, Alireza (2019) Survivin modulatory role in autoimmune and autoinflammatory diseases. En: Journal of Cellular Physiology. Vol. 234; No. 11; pp. 19440 - 19450; Disponible en: 10.1002/jcp.28725.
Littlejohn, Emily A.; Monrad, Seetha U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. En: Primary Care: Clinics in Office Practice. Vol. 45; No. 2; pp. 237 - 255; Disponible en: 10.1016/j.pop.2018.02.010.
Smith, M. D.; Weedon, H.; Papangelis, V.; Walker, J.; Roberts-Thomson, P. J.; Ahern, M. J. (2010) Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. En: Rheumatology. Vol. 49; No. 5; pp. 862 - 875; Disponible en: 10.1093/rheumatology/kep467.
Erlandsson, Malin C.; Forslind, Kristina; Andersson, Sofia E. M.; Lund, Annelie; Bokarewa, Maria I. (2012) Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA. En: Rheumatology. Vol. 51; No. 5; pp. 932 - 940; Disponible en: 10.1093/rheumatology/ker362.
Park, M-C; Chung, S-J; Park, Y-B; Lee, S-K (2008) Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis. En: Clinical and experimental rheumatology. Vol. 26; No. 5; pp. 881 - 6;
Wasén, Caroline; Turkkila, Minna; Bossios, Apostolos; Erlandsson, Malin; Andersson, Karin M.; Ekerljung, Linda; Malmhäll, Carina; Brisslert, Mikael; Töyrä Silfverswärd, Sofia; Lundbäck, Bo; Bokarewa, Maria I. (2017) Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis. En: Journal of Autoimmunity. Vol. 78; pp. 101 - 110; Disponible en: 10.1016/j.jaut.2016.12.009.
Turkkila, Minna; Andersson, Karin M.E.; Amu, Sylvie; Brisslert, Mikael; Erlandsson, Malin C.; Silfverswärd, Sofia; Bokarewa, Maria I. (2015) Suppressed diversity of survivin splicing in active rheumatoid arthritis. En: Arthritis Research & Therapy. Vol. 17; No. 1; pp. 175 - 175; Disponible en: 10.1186/s13075-015-0689-z.
Andersson, Karin M.E.; Turkkila, Minna; Erlandsson, Malin C.; Bossios, Apostolos; Silfverswärd, Sofia Töyrä; Hu, Dan; Ekerljung, Linda; Malmhäll, Carina; Weiner, Howard L.; Lundbäck, Bo; Bokarewa, Maria I. (2017) Survivin controls biogenesis of microRNA in smokers: A link to pathogenesis of rheumatoid arthritis. En: Biochimica et Biophysica Acta (BBA). Vol. 1863; No. 3; pp. 663 - 673; Disponible en: 10.1016/j.bbadis.2016.11.033.
Erlandsson, Malin C.; Turkkila, Minna; Siljehult, Filip; Pullerits, Rille; Eriksson, Catharina; Rantapää-Dahlqvist, Solbritt; Bokarewa, Maria I. (2018) Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden. En: Seminars in Arthritis and Rheumatism. Vol. 47; No. 6; pp. 778 - 785; Disponible en: 10.1016/j.semarthrit.2017.10.020.
Baran, Marcin; Möllers, Linda Nilsson; Andersson, Sofia; Jonsson, Ing‐Marie; Ekwall, Anna‐Karin Hultgård; Bjersing, Jan; Tarkowski, Andrej; Bokarewa, Maria (2009) Survivin is an essential mediator of arthritis interacting with urokinase signalling. En: Journal of Cellular and Molecular Medicine. Vol. 13; No. 9b; pp. 3797 - 3808; Disponible en: 10.1111/j.1582-4934.2009.00721.x.
Jenko, Barbara; Praprotnik, Sonja; Čučnik, Saša; Rotar, Žiga; Tomšič, Matija; Dolžan, Vita (2016) Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients. En: Pharmacogenomics. Vol. 17; No. 1; pp. 45 - 9; Disponible en: 10.2217/pgs.15.147.
Ma, Sha; Wang, Jing; Lin, Jun; Jin, Song; He, Fang; Mei, Jian; Zhang, Hong; Wang, Shuya; Li, Qin (2021) Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the NOTCH pathway. En: International Journal of Rheumatic Diseases. Vol. 24; No. 7; pp. 922 - 929; Disponible en: 10.1111/1756-185X.14150.
Ebrahimiyan, Hamidreza; Rezaei, Nima; Vojdanian, Mahdi; Aslani, Saeed; Jamshidi, Ahmadreza; Mahmoudi, Mahdi (2019) microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. En: International Journal of Rheumatic Diseases. Vol. 22; No. 6; pp. 1107 - 1114; Disponible en: 10.1111/1756-185X.13520.
Chen, Danna; Liu, Dongdong; Liu, Dan; He, Min; Peng, Anping; Xu, Jiarui; Lin, Li; Luo, Fudong; Chen, Lin; Huang, Xianzhang; Zhuang, Junhua; Xu, Jianhua (2017) Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing. En: Scientific Reports. Vol. 7; No. 1; pp. 367 - 367; Disponible en: 10.1038/s41598-017-00517-w.
YANG, SHUZHONG; YANG, YOUGENG (2015) Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis. En: Molecular Medicine Reports. Vol. 12; No. 2; pp. 2395 - 2401; Disponible en: 10.3892/mmr.2015.3642.
Mokuda, Sho; Miyazaki, Tatsuhiko; Ito, Yuki; Yamasaki, Satoshi; Inoue, Hiroko; Guo, Yun; Kong, Weng-Sheng; Kanno, Masamoto; Takasugi, Kiyoshi; Sugiyama, Eiji; Masumoto, Junya (2015) The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. En: Scientific Reports. Vol. 5; No. 1; pp. 9795 - 9795; Disponible en: 10.1038/srep09795.
Mera, Simona; Magnusson, Mattias; Tarkowski, Andrej; Bokarewa, Maria (2008) Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. En: Journal of Leukocyte Biology. Vol. 83; No. 1; pp. 149 - 155; Disponible en: 10.1189/jlb.0507287.
Long, Xian Ming (2014) Expression of Survivin in Patients With Refractory Rheumatoid Arthritis in a Chinese Population. En: Archives of Rheumatology. Vol. 29; No. 2; pp. 81 - 87; Disponible en: 10.5606/ArchRheumatol.2014.3841.
Liu, Yun; Aryee, Martin J; Padyukov, Leonid; Fallin, M Daniele; Hesselberg, Espen; Runarsson, Arni; Reinius, Lovisa; Acevedo, Nathalie; Taub, Margaret; Ronninger, Marcus; Shchetynsky, Klementy; Scheynius, Annika; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Ekström, Tomas J; Feinberg, Andrew P (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. En: Nature Biotechnology. Vol. 31; No. 2; pp. 142 - 147; Disponible en: 10.1038/nbt.2487.
Klein, Kerstin; Gay, Steffen (2015) Epigenetics in rheumatoid arthritis. En: Current opinion in rheumatology. Vol. 27; No. 1; pp. 76 - 82; Disponible en: 10.1097/BOR.0000000000000128.
Vandeputte, Doris; Kathagen, Gunter; D’hoe, Kevin; Vieira-Silva, Sara; Valles-Colomer, Mireia; Sabino, João; Wang, Jun; Tito, Raul Y.; De Commer, Lindsey; Darzi, Youssef; Vermeire, Séverine; Falony, Gwen; Raes, Jeroen (2017) Quantitative microbiome profiling links gut community variation to microbial load. En: Nature. Vol. 551; No. 7681; pp. 507 - 511; Disponible en: 10.1038/nature24460.
Maeda, Yuichi; Takeda, Kiyoshi (2019) Host–microbiota interactions in rheumatoid arthritis. En: Experimental & Molecular Medicine. Vol. 51; No. 12; pp. 1 - 6; Disponible en: 10.1038/s12276-019-0283-6.
Pimsen, Apiradee; Kao, Chi-Yin; Hsu, Sheng-Tzu; Shu, Bih-Ching (2022) The Effect of Advance Care Planning Intervention on Hospitalization Among Nursing Home Residents: A Systematic Review and Meta-Analysis. En: Journal of the American Medical Directors Association. Vol. 23; No. 9; pp. 1448 - 1460.e1; Disponible en: 10.1016/j.jamda.2022.07.017.
Bansal, Nancy; Pasricha, Chirag; Kumari, Pratima; Jangra, Sarita; Kaur, Rupinder; Singh, Ravinder (2023) A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management. En: Autoimmunity Reviews. Vol. 22; No. 7; pp. 103337 - 103337; Disponible en: 10.1016/j.autrev.2023.103337.
Giancane, Gabriella; Consolaro, Alessandro; Lanni, Stefano; Davì, Sergio; Schiappapietra, Benedetta; Ravelli, Angelo (2016) Juvenile Idiopathic Arthritis: Diagnosis and Treatment. En: Rheumatology and Therapy. Vol. 3; No. 2; pp. 187 - 207; Disponible en: 10.1007/s40744-016-0040-4.
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/ce8f1bcf-62ce-4da7-95ee-49834a6d7776/download
https://repository.urosario.edu.co/bitstreams/c1d0ed03-476c-457a-941d-162786df24de/download
https://repository.urosario.edu.co/bitstreams/7f9924f3-38e4-46c1-a6bf-9e0a1a47c052/download
https://repository.urosario.edu.co/bitstreams/d21242a7-e29e-43b5-957e-aee369f15204/download
https://repository.urosario.edu.co/bitstreams/5d2972cc-6c52-4592-be3f-5e3f0c00a44d/download
https://repository.urosario.edu.co/bitstreams/1fe74377-6ba5-4ceb-b378-a84a07b54cdc/download
bitstream.checksum.fl_str_mv afae44c56de18a3c95484c7d36a3f8d6
617b5754a3e0f1fa52d58569bee1858f
b2825df9f458e9d5d96ee8b7cd74fde6
3b6ce8e9e36c89875e8cf39962fe8920
1fa4f1f0c377618f10b6410bd4b0b0dc
b579d5c82d91572dcf7314cbc305e30e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167497517039616
spelling Rojas Quintana, Manuel Eduardo1110541485600Acosta Ampudia, Yeny Yasbleidy38361933600Centro de Estudio de Enfermedades Autoinmunes - CREAGuerrero Acosta, NicolásEspecialista en Epidemiología (en Convenio con el CES)EspecializaciónFull timeb41e15f4-5a64-434f-88c3-470b2d86fc112024-07-10T14:29:24Z2024-07-10T14:29:24Z2024-06-10Antecedentes: La Artritis Reumatoide (AR) es una enfermedad autoinmune, caracterizada por un daño articular progresivo que limita la calidad de vida y años laborales de los pacientes, y un alto costo para los sistemas de salud. Aún se desconoce completamente su fisiopatología, sin embargo, se han realizado estudios en busca de nuevos biomarcadores para su diagnóstico. La Survivina aparentemente está implicada en la fisiopatología de la enfermedad y es un potencial biomarcador en esta condición. Objetivos: Integrar la evidencia del papel de la proteína Survivina y su asociación con la AR y Artritis Idiopática Juvenil (AIJ), a través de una revisión sistemática de la literatura. Métodos de búsqueda: Se hicieron búsquedas en las siguientes bases de datos hasta abril de 2023: PubMed, EMBASE, y CINAHL. Criterios de selección: Se incluyeron todos los estudios observacionales analíticos y ensayos clínicos que incluían pacientes con AR o AIJ, y controles sanos, que evaluaran la presencia de Survivina en suero, plasma o líquido sinovial detectado por medio de ELISA o qPCR. Obtención y análisis de los datos: Dos investigadores revisaron y evaluaron de forma independiente la literatura para inclusión y riesgo de sesgo, se extrajeron los datos y verificaron su exactitud, se construyó la base de datos con las variables incluidas. Para la positividad de Survivina se usó la estimación de OR usando modelo de efectos aleatorios, y para el caso de los valores cuantitativos usamos la diferencia de medias estandarizadas (DME). Resultados principales: El meta-análisis incluyó siete estudios, 5 estudios incluyeron casos y controles (n: 3 para AR, y n: 2 AIJ) y 2 fueron estudios transversales (AR). Los pacientes con AR/AIJ tuvieron una mayor positividad para Survivina en suero en comparación con los controles (913/1738 [52,5%] frente a 245/2010 [ 12,1%]) con un OR 13,89 [IC 95%, 1,74- 110,89]). El análisis de DME confirmó que los pacientes con AR/AIJ presentan niveles más elevados de Survivina en comparación con los controles (DME = 2,05 [IC del 95 %: 0,55-3,56]). Respecto a líquido sinovial, estudios demostraron niveles elevados de Survivina en líquido sinovial en pacientes con AIJ y AR en comparación con controles, mediante ELISA, inmunohistoquímica, entre otras. Así mismo, diferentes estudios han reportado la correlación entre niveles elevados de Survivina, con tabaquismo y positividad de autoanticuerpos (FR y ACPAs). 12 Conclusiones: La Survivina es un potencial biomarcador para el diagnóstico de AR/AIJ. Estudios que evalúen si el biomarcador de artritis-especifico, así como su importancia en la actividad de la enfermedad y el pronóstico, son necesarios.Background: Rheumatoid arthritis (RA) is an autoimmune disease characterized by progressive joint damage that limits patients' quality of life and working years, generating high costs for healthcare systems. Its pathophysiology is still completely unknown; however, studies have been conducted in search of new biomarkers for its diagnosis. Survivin is apparently involved in the pathophysiology of the disease and is a potential biomarker in this condition. Objectives: To integrate the evidence on the role of the Survivin protein and its association with RA and Juvenile Idiopathic Arthritis (JIA), through a systematic review of the literature. Search methods: Searches were conducted in the following databases until April 2023: PubMed, EMBASE, and CINAHL. Selection criteria: Were included all analytical observational studies and clinical trials including patients with RA or JIA versus controls, evaluating the presence of Survivin in serum, plasma, or synovial fluid detected by ELISA or qPCR. Data collection and analysis: Two researchers independently reviewed and assessed the literature for inclusion and risk of bias, extracted data and checked their accuracy, and constructed the database with the included variables. For Survivin positivity, the OR was estimated using a random effects model, and for quantitative values we used the standardized mean difference (SMD). Main results: The meta-analysis included seven studies, five studies included case-control studies (n: 3 for RA, and n: 2 JIA) and two were cross-sectional studies (RA). RA/JIA patients had higher serum Survivin positivity compared to controls (913/1738 [52.5%] vs. 245/2010 [12.1%]) with an OR (13.89 [95% CI, 1.74-110.89]). SMD analysis confirmed that RA/JIA patients have higher levels of Survivin compared to controls (SMD = 2.05 [95% CI, 0.55-3.56]). Regarding synovial fluid, studies demonstrated elevated levels of Survivin in synovial fluid in JIA and RA patients compared to controls, as measured by ELISA, immunohistochemistry, among others. Likewise, different studies have reported a correlation between elevated levels of Survivin and both smoking and positivity of autoantibodies (RF and ACPAs). Conclusions: Survivin is a potential biomarker for the diagnosis of RA/JIA. Studies evaluating the suitability of this arthritis-specific biomarker is suitable, as well as its importance in disease activity and prognosis, are needed.70 ppapplication/pdfhttps://repository.urosario.edu.co/handle/10336/42989spaUniversidad del RosarioUniversidad CES. Facultad de MedicinaEscuela de Medicina y Ciencias de la SaludEspecialización en EpidemiologíaAttribution-NonCommercial-NoDerivatives 4.0 InternationalAbierto (Texto Completo)EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.http://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2Smolen, Josef S; Aletaha, Daniel; McInnes, Iain B (2016) Rheumatoid arthritis. En: The Lancet. Vol. 388; No. 10055; pp. 2023 - 2038; Disponible en: 10.1016/S0140-6736(16)30173-8.Finckh, Axel; Gilbert, Benoît; Hodkinson, Bridget; Bae, Sang-Cheol; Thomas, Ranjeny; Deane, Kevin D.; Alpizar-Rodriguez, Deshiré; Lauper, Kim (2022) Global epidemiology of rheumatoid arthritis. En: Nature Reviews Rheumatology. Disponible en: 10.1038/s41584-022-00827-y.Birnbaum, Howard; Pike, Crystal; Kaufman, Rebecca; Maynchenko, Maryna; Kidolezi, Yohanne; Cifaldi, Mary (2010) Societal cost of rheumatoid arthritis patients in the US. En: Current Medical Research and Opinion. Vol. 26; No. 1; pp. 77 - 90; Disponible en: 10.1185/03007990903422307.Joensuu, Jaana T.; Huoponen, Saara; Aaltonen, Kalle J.; Konttinen, Yrjö T.; Nordström, Dan; Blom, Marja (2015) The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review. En: PLOS ONE. Vol. 10; No. 3; pp. e0119683 - e0119683; Disponible en: 10.1371/journal.pone.0119683.Zafari, Parisa; Rafiei, Alireza; Esmaeili, Seyed‐Alireza; Moonesi, Mohammadreza; Taghadosi, Mahdi (2019) Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. En: Journal of Cellular Physiology. Vol. 234; No. 12; pp. 21575 - 21587; Disponible en: 10.1002/jcp.28784.Yamanishi, Yuji; Boyle, David L.; Rosengren, Sanna; Green, Douglas R.; Zvaifler, Nathan J.; Firestein, Gary S. (2002) Regional analysis of p53 mutations in rheumatoid arthritis synovium. En: Proceedings of the National Academy of Sciences. Vol. 99; No. 15; pp. 10025 - 10030; Disponible en: 10.1073/pnas.152333199.Radu, Andrei-Flavius; Bungau, Simona Gabriela (2021) Management of Rheumatoid Arthritis: An Overview. En: Cells. Vol. 10; No. 11; pp. 2857 - 2857; Disponible en: 10.3390/cells10112857.Moher, David; Liberati, Alessandro; Tetzlaff, Jennifer; Altman, Douglas G. (2010) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. En: International Journal of Surgery. Vol. 8; No. 5; pp. 336 - 341; Disponible en: 10.1016/j.ijsu.2010.02.007.Kerkman, Priscilla F; Kempers, Ayla C; van der Voort, Ellen I H; van Oosterhout, Maikel; Huizinga, Tom W J; Toes, René E M; Scherer, Hans U (2016) Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies. En: Annals of the Rheumatic Diseases. Vol. 75; No. 12; pp. 2201 - 2207; Disponible en: 10.1136/annrheumdis-2015-208554.Lin, Yen-Ju; Anzaghe, Martina; Schülke, Stefan (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. En: Cells. Vol. 9; No. 4; pp. 880 - 880; Disponible en: 10.3390/cells9040880.Fernández-Ávila, Daniel G.; Rincón-Riaño, Diana N.; Bernal-Macías, Santiago; Gutiérrez Dávila, Juan M.; Rosselli, Diego (2019) Prevalencia de la artritis reumatoide en Colombia según información del Sistema Integral de Información de la Protección Social. En: Revista Colombiana de Reumatología. Vol. 26; No. 2; pp. 83 - 87; Disponible en: 10.1016/j.rcreu.2019.01.003.Radwan‐Oczko, Małgorzata; Duś‐Ilnicka, Irena; Richards, Pamela; Thomsen, Anna Marie; Rasmussen, Claus (2019) Rheumatoid arthritis patients' oral health and disease activity. En: International Journal of Rheumatic Diseases. pp. 1756 - 185X.13590; Disponible en: 10.1111/1756-185X.13590.Wegner, Natalia; Lundberg, Karin; Kinloch, Andrew; Fisher, Benjamin; Malmström, Vivianne; Feldmann, Marc; Venables, Patrick J. (2010) Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. En: Immunological Reviews. Vol. 233; No. 1; pp. 34 - 54; Disponible en: 10.1111/j.0105-2896.2009.00850.x.Kurowska, Weronika; Kuca-Warnawin, Ewa H.; Radzikowska, Anna; Maśliński, Włodzimierz (2017) The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. En: Central European Journal of Immunology. Vol. 42; No. 4; pp. 390 - 398; Disponible en: 10.5114/ceji.2017.72807.Gómez, Antonio (2011) Nuevos criterios de clasificación de artritis reumatoide. En: Reumatología Clínica. Vol. 6; pp. 33 - 37; Disponible en: 10.1016/j.reuma.2011.01.002.Aletaha, D.; Neogi, T.; Silman, A. J.; Funovits, J.; Felson, D. T.; Bingham, C. O.; Birnbaum, N. S.; Burmester, G. R.; Bykerk, V. P.; Cohen, M. D.; Combe, B.; Costenbader, K. H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J. M.; Hobbs, K.; Huizinga, T. W.; Kavanaugh, A.; Kay, J.; Kvien, T. K.; Laing, T.; Mease, P.; Menard, H. A.; Moreland, L. W.; Naden, R. L.; Pincus, T.; Smolen, J. S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P. P.; Upchurch, K. S.; Vencovsky, J.; Wolfe, F.; Hawker, G. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. En: Annals of the Rheumatic Diseases. Vol. 69; No. 9; pp. 1580 - 1588; Disponible en: 10.1136/ard.2010.138461.Khodashahi, Mandana; Saadati, Nayyereh; Sahebari, Maryam; Rezaieyazdi, Zahra; Rastgou, Neda (2020) Diagnostic Role of Survivin in Rheumatoid Arthritis: A Systematic Review. En: Current Rheumatology Reviews. Vol. 16; No. 4; pp. 267 - 279; Disponible en: 10.2174/1573397116666200116095039.Page, Matthew J; McKenzie, Joanne E; Bossuyt, Patrick M; Boutron, Isabelle; Hoffmann, Tammy C; Mulrow, Cynthia D; Shamseer, Larissa; Tetzlaff, Jennifer M; Akl, Elie A; Brennan, Sue E; Chou, Roger; Glanville, Julie; Grimshaw, Jeremy M; Hróbjartsson, Asbjørn; Lalu, Manoj M; Li, Tianjing; Loder, Elizabeth W; Mayo-Wilson, Evan; McDonald, Steve; McGuinness, Luke A; Stewart, Lesley A; Thomas, James; Tricco, Andrea C; Welch, Vivian A; Whiting, Penny; Moher, David (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. En: BMJ. pp. n71 - n71; Disponible en: 10.1136/bmj.n71.Sociedad Española de Reumatología., Alejandro; Pascual-Salcedo, Dora; Martín-Mola, Emilio (2000) Revista española de reumatología : órgano oficial de la Sociedad Española de Reumatología. En: Revista Española de Reumatología. Vol. 27; No. 6; pp. 247 - 249; La Sociedad; Disponible en: http://www.elsevier.es/es-revista-revista-espanola-reumatologia-29-articulo-artritis-reumatoide-11712.Anaya, J. M.; Shoenfeld, Y.; Rojas-Villarraga, A.; Levy, R. A.; Cervera, R. (2013) Autoimmunity: From Bench to Bedside. Bogota: El Rosario University Press.; 9789587383669;Anaya, Juan-Manuel (2014) The diagnosis and clinical significance of polyautoimmunity. En: Autoimmunity Reviews. Vol. 13; No. 4-5; pp. 423 - 426; Disponible en: 10.1016/j.autrev.2014.01.049.Wang, Lifeng; Wang, Fu-Sheng; Gershwin, M. Eric (2015) Human autoimmune diseases: a comprehensive update. En: Journal of Internal Medicine. Vol. 278; No. 4; pp. 369 - 395; Disponible en: 10.1111/joim.12395.Moroni, Luca; Bianchi, Ilaria; Lleo, Ana (2012) Geoepidemiology, gender and autoimmune disease. En: Autoimmunity Reviews. Vol. 11; No. 6-7; pp. A386 - A392; Disponible en: 10.1016/j.autrev.2011.11.012.Anaya, Juan-Manuel (2010) The autoimmune tautology. En: Arthritis Research & Therapy. Vol. 12; No. 6; pp. 147 - 147; Disponible en: 10.1186/ar3175.van der Woude, Diane; van der Helm-van Mil, Annette H.M. (2018) Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. En: Best Practice & Research Clinical Rheumatology. Vol. 32; No. 2; pp. 174 - 187; Disponible en: 10.1016/j.berh.2018.10.005.Littlejohn, Emily A.; Monrad, Seetha U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. En: Primary Care: Clinics in Office Practice. Vol. 45; No. 2; pp. 237 - 255; Disponible en: 10.1016/j.pop.2018.02.010.Sparks, Jeffrey A. (2019) Rheumatoid Arthritis. En: Annals of Internal Medicine. Vol. 170; No. 1; pp. ITC1 - ITC1; Disponible en: 10.7326/AITC201901010.Burmester, Gerd R; Pope, Janet E (2017) Novel treatment strategies in rheumatoid arthritis. En: The Lancet. Vol. 389; No. 10086; pp. 2338 - 2348; Disponible en: 10.1016/S0140-6736(17)31491-5.Ouzzani, Mourad; Hammady, Hossam; Fedorowicz, Zbys; Elmagarmid, Ahmed (2016) Rayyan—a web and mobile app for systematic reviews. En: Systematic Reviews. Vol. 5; No. 1; pp. 210 - 210; Disponible en: 10.1186/s13643-016-0384-4.Petty, Ross E; Southwood, Taunton R; Manners, Prudence; Baum, John; Glass, David N; Goldenberg, Jose; He, Xiaohu; Maldonado-Cocco, Jose; Orozco-Alcala, Javier; Prieur, Anne-Marie; Suarez-Almazor, Maria E; Woo, Patricia; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. En: The Journal of rheumatology. Vol. 31; No. 2; pp. 390 - 2;Sah, Nand K.; Seniya, Chandrabhan (2015) Survivin splice variants and their diagnostic significance. En: Tumor Biology. Vol. 36; No. 9; pp. 6623 - 6631; Disponible en: 10.1007/s13277-015-3865-5.Mahotka, C; Wenzel, M; Springer, E; Gabbert, H E; Gerharz, C D (1999) Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. En: Cancer research. Vol. 59; No. 24; pp. 6097 - 102;Badran, Adel; Yoshida, Akira; Ishikawa, Keiko; Goi, Takanori; Yamaguchi, Akio; Ueda, Takanori; Inuzuka, Manabu (2004) Identification of a novel splice variant of the human anti-apoptopsis gene survivin. En: Biochemical and Biophysical Research Communications. Vol. 314; No. 3; pp. 902 - 907; Disponible en: 10.1016/j.bbrc.2003.12.178.Caldas, Hugo; Honsey, Laura E; Altura, Rachel A (2005) Survivin 2α: a novel Survivin splice variant expressed in human malignancies. En: Molecular Cancer. Vol. 4; No. 1; pp. 11 - 11; Disponible en: 10.1186/1476-4598-4-11.Scherer, Hans Ulrich; Häupl, Thomas; Burmester, Gerd R. (2020) The etiology of rheumatoid arthritis. En: Journal of Autoimmunity. Vol. 110; pp. 102400 - 102400; Disponible en: 10.1016/j.jaut.2019.102400.Andersen, Mads Hald; Svane, Inge Marie; Becker, Jürgen C.; Straten, Per thor (2007) The Universal Character of the Tumor-Associated Antigen Survivin. En: Clinical Cancer Research. Vol. 13; No. 20; pp. 5991 - 5994; Disponible en: 10.1158/1078-0432.CCR-07-0686.Arnett, Frank C.; Edworthy, Steven M.; Bloch, Daniel A.; Mcshane, Dennis J.; Fries, James F.; Cooper, Norman S.; Healey, Louis A.; Kaplan, Stephen R.; Liang, Matthew H.; Luthra, Harvinder S.; Medsger, Thomas A.; Mitchell, Donald M.; Neustadt, David H.; Pinals, Robert S.; Schaller, Jane G.; Sharp, John T.; Wilder, Ronald L.; Hunder, Gene G. (1988) The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. En: Arthritis & Rheumatism. Vol. 31; No. 3; pp. 315 - 324; Disponible en: 10.1002/art.1780310302.Moola S; Munn Z; Tufanaru C; Aromataris E; Sears K; Sfetcu R; Currie M; Qureshi R; Mattis P; Lisy K; Mu P-F (2020) Chapter 7: Systematic reviews of etiology and risk. En: JBI Manual for Evidence Synthesis.: JBI; Disponible en: 10.46658/JBIMES-20-08.Galeotti, L; Adrian, K; Berg, S; Tarkowski, A; Bokarewa, M (2008) Circulating survivin indicates severe course of juvenile idiopathic arthritis. En: Clinical and experimental rheumatology. Vol. 26; No. 2; pp. 373 - 8;Chun-Lai, Too; Murad, Shahnaz; Erlandsson, Malin C.; Hussein, Heselynn; Sulaiman, Wahinuddin; Dhaliwal, Jasbir S.; Bokarewa, Maria I. (2015) Recognizing Rheumatoid Arthritis: Oncoprotein Survivin Opens New Possibilities. En: Medicine. Vol. 94; No. 4; pp. e468 - e468; Disponible en: 10.1097/MD.0000000000000468.Baraka, Eman Abdel Alim; El Din, Mounir Serag; El Shambky, Ahmed; Fouad, Nehad A.; Abdelkader, Mona Abdullah (2019) Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity. En: Egyptian Rheumatology and Rehabilitation. Vol. 46; No. 4; pp. 221 - 228; Disponible en: 10.4103/err.err_40_19.Lipinska, Joanna; Kaszkowiak, Marcin; Malachowska, Beata; Swidrowska-Jaros, Joanna; Smolewska, Elzbieta (2021) Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value—a single-center study. En: Arthritis Research & Therapy. Vol. 23; No. 1; pp. 40 - 40; Disponible en: 10.1186/s13075-021-02424-y.Radwan, Abdullah; Allam, Ahmed (2021) Clinical significance of serum survivin in rheumatoid arthritis patients: Relation to disease activity, functional status and radiological damage. En: The Egyptian Rheumatologist. Vol. 43; No. 2; pp. 109 - 113; Disponible en: 10.1016/j.ejr.2020.12.008.Bokarewa, Maria; Lindblad, Sofia; Bokarew, Dmitriy; Tarkowski, Andrej (2005) Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. En: Arthritis research & therapy. Vol. 7; No. 2; pp. R349 - 58; Disponible en: 10.1186/ar1498.Svensson, Björn; Hafström, Ingiäld; Erlandsson, Malin C; Forslind, Kristina; Bokarewa, Maria I (2014) Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study. En: Arthritis Research & Therapy. Vol. 16; No. 1; pp. R12 - R12; Disponible en: 10.1186/ar4438.Li, Fengzhi; Ling, Xiang (2006) Survivin study: An update of “What is the next wave?”. En: Journal of Cellular Physiology. Vol. 208; No. 3; pp. 476 - 486; Disponible en: 10.1002/jcp.20634.Prasad, Peeyush; Verma, Sneha; Surbhi; Ganguly, Nirmal Kumar; Chaturvedi, Ved; Mittal, Shivani Arora (2023) Rheumatoid arthritis: advances in treatment strategies. En: Molecular and Cellular Biochemistry. Vol. 478; No. 1; pp. 69 - 88; Disponible en: 10.1007/s11010-022-04492-3.Perumal, Narayanan B.; Kaplan, Mark H. (2011) Regulating Il9 transcription in T helper cells. En: Trends in Immunology. Vol. 32; No. 4; pp. 146 - 150; Disponible en: 10.1016/j.it.2011.01.006.Isgren, Anniella; Forslind, Kristina; Erlandsson, Malin; Axelsson, Carl; Andersson, Sofia; Lund, Anneli; Bokarewa, Maria (2012) High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis. En: Seminars in Arthritis and Rheumatism. Vol. 41; No. 5; pp. 652 - 657; Disponible en: 10.1016/j.semarthrit.2011.08.005.Erlandsson, Malin C.; Turkkila, Minna; Pullerits, Rille; Bokarewa, Maria I. (2018) Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA—Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA. En: Frontiers in Medicine. Vol. 5; Disponible en: 10.3389/fmed.2018.00219.Svensson, Björn; Hafström, Ingiäld; Forslind, Kristina; Albertsson, Kristina; Tarkowski, Andrej; Bokarewa, Maria (2010) Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis. En: Annals of Medicine. Vol. 42; No. 1; pp. 45 - 54; Disponible en: 10.3109/07853890903376280.van der Heijde, D M; van Leeuwen, M A; van Riel, P L; van de Putte, L B (1995) Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). En: The Journal of rheumatology. Vol. 22; No. 9; pp. 1792 - 6;Chaudhary, Ajay K.; Yadav, Neelu; Bhat, Tariq A.; O’Malley, Jordan; Kumar, Sandeep; Chandra, Dhyan (2016) A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapy. En: Drug Discovery Today. Vol. 21; No. 1; pp. 38 - 47; Disponible en: 10.1016/j.drudis.2015.07.014.Dharmapatni, Anak ASSK; Smith, Malcolm D; Findlay, David M; Holding, Christopher A; Evdokiou, Andreas; Ahern, Michael J; Weedon, Helen; Chen, Paul; Screaton, Gavin; Xu, Xiao N; Haynes, David R (2009) Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. En: Arthritis Research & Therapy. Vol. 11; No. 1; pp. R13 - R13; Disponible en: 10.1186/ar2603.Ahn, Joong Kyong; Oh, Ji-Min; Lee, Jaejoon; Bae, Eun-Kyung; Ahn, Kwang-Sung; Cha, Hoon-Suk; Koh, Eun-Mi (2010) Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. En: Inflammation. Vol. 33; No. 6; pp. 381 - 8; Disponible en: 10.1007/s10753-010-9196-1.Prahalad, Sampath; Glass, David N (2002) Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?. En: Arthritis Research. Vol. 4; No. Suppl 3; pp. 303 - 303; Disponible en: 10.1186/ar594.Chang, Jang-Yang; Cheung, Chun Hei Antonio; Huang, Chien-Chang; Tsai, Fang-Ying; Lee, Jane Ying-Chieh; Cheng, Siao Muk; Chang, Yung-Chieh; Huang, Yi-Chun; Chen, Shang-Hung (2013) Survivin. En: OncoTargets and Therapy. pp. 1453 - 1453; Disponible en: 10.2147/OTT.S33374.Li, Fengzhi (2003) Survivin study: What is the next wave?. En: Journal of Cellular Physiology. Vol. 197; No. 1; pp. 8 - 29; Disponible en: 10.1002/jcp.10327.Gravina, G.; Wasén, C.; Garcia-Bonete, M.J.; Turkkila, M.; Erlandsson, M.C.; Töyrä Silfverswärd, S.; Brisslert, M.; Pullerits, R.; Andersson, K.M.; Katona, G.; Bokarewa, M.I. (2017) Survivin in autoimmune diseases. En: Autoimmunity Reviews. Vol. 16; No. 8; pp. 845 - 855; Disponible en: 10.1016/j.autrev.2017.05.016.Kitagawa, Mayumi; Lee, Sang Hyun (2015) The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis. En: Frontiers in Cell and Developmental Biology. Vol. 3; Disponible en: 10.3389/fcell.2015.00014.Eckelman, Brendan P; Salvesen, Guy S; Scott, Fiona L (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. En: EMBO reports. Vol. 7; No. 10; pp. 988 - 994; Disponible en: 10.1038/sj.embor.7400795.Araya, Luam E.; Soni, Ishankumar V.; Hardy, Jeanne A.; Julien, Olivier (2021) Deorphanizing Caspase-3 and Caspase-9 Substrates In and Out of Apoptosis with Deep Substrate Profiling. En: ACS Chemical Biology. Vol. 16; No. 11; pp. 2280 - 2296; Disponible en: 10.1021/acschembio.1c00456.Altznauer, Frank; Martinelli, Sibylla; Yousefi, Shida; Thürig, Christine; Schmid, Inès; Conway, Edward M.; Schöni, Martin H.; Vogt, Peter; Mueller, Christoph; Fey, Martin F.; Zangemeister-Wittke, Uwe; Simon, Hans-Uwe (2004) Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils. En: The Journal of Experimental Medicine. Vol. 199; No. 10; pp. 1343 - 1354; Disponible en: 10.1084/jem.20032033.Xing, Zheng; Conway, Edward M.; Kang, Chulho; Winoto, Astar (2004) Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis. En: The Journal of Experimental Medicine. Vol. 199; No. 1; pp. 69 - 80; Disponible en: 10.1084/jem.20031588.Bokarewa, Maria; Brink, Mikael; Erlandsson, Malin; Rantapää Dahlqvist, Solbritt (2014) Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study. En: Arthritis Research & Therapy. Vol. 16; No. 1; pp. R45 - R45; Disponible en: 10.1186/ar4474.Levitsky, Adrian; Erlandsson, Malin C.; van Vollenhoven, Ronald F.; Bokarewa, Maria I. (2015) Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. En: BMC Medicine. Vol. 13; No. 1; pp. 247 - 247; Disponible en: 10.1186/s12916-015-0485-2.Shi, Rui; Chen, Muzhi; Litifu, Bahaerguli; Zhaorigetu (2018) Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis. En: Modern Rheumatology. Vol. 28; No. 1; pp. 126 - 132; Disponible en: 10.1080/14397595.2017.1317384.Figus, Fabiana Assunta; Piga, Matteo; Azzolin, Irene; McConnell, Rebecca; Iagnocco, Annamaria (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. En: Autoimmunity Reviews. Vol. 20; No. 4; pp. 102776 - 102776; Disponible en: 10.1016/j.autrev.2021.102776.Pahlavan, Yasamin; kahroba, Houman; Samadi, Nasser; Karimi, Abbas; Ansarin, Khalil; Khabbazi, Alireza (2019) Survivin modulatory role in autoimmune and autoinflammatory diseases. En: Journal of Cellular Physiology. Vol. 234; No. 11; pp. 19440 - 19450; Disponible en: 10.1002/jcp.28725.Littlejohn, Emily A.; Monrad, Seetha U. (2018) Early Diagnosis and Treatment of Rheumatoid Arthritis. En: Primary Care: Clinics in Office Practice. Vol. 45; No. 2; pp. 237 - 255; Disponible en: 10.1016/j.pop.2018.02.010.Smith, M. D.; Weedon, H.; Papangelis, V.; Walker, J.; Roberts-Thomson, P. J.; Ahern, M. J. (2010) Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. En: Rheumatology. Vol. 49; No. 5; pp. 862 - 875; Disponible en: 10.1093/rheumatology/kep467.Erlandsson, Malin C.; Forslind, Kristina; Andersson, Sofia E. M.; Lund, Annelie; Bokarewa, Maria I. (2012) Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA. En: Rheumatology. Vol. 51; No. 5; pp. 932 - 940; Disponible en: 10.1093/rheumatology/ker362.Park, M-C; Chung, S-J; Park, Y-B; Lee, S-K (2008) Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis. En: Clinical and experimental rheumatology. Vol. 26; No. 5; pp. 881 - 6;Wasén, Caroline; Turkkila, Minna; Bossios, Apostolos; Erlandsson, Malin; Andersson, Karin M.; Ekerljung, Linda; Malmhäll, Carina; Brisslert, Mikael; Töyrä Silfverswärd, Sofia; Lundbäck, Bo; Bokarewa, Maria I. (2017) Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis. En: Journal of Autoimmunity. Vol. 78; pp. 101 - 110; Disponible en: 10.1016/j.jaut.2016.12.009.Turkkila, Minna; Andersson, Karin M.E.; Amu, Sylvie; Brisslert, Mikael; Erlandsson, Malin C.; Silfverswärd, Sofia; Bokarewa, Maria I. (2015) Suppressed diversity of survivin splicing in active rheumatoid arthritis. En: Arthritis Research & Therapy. Vol. 17; No. 1; pp. 175 - 175; Disponible en: 10.1186/s13075-015-0689-z.Andersson, Karin M.E.; Turkkila, Minna; Erlandsson, Malin C.; Bossios, Apostolos; Silfverswärd, Sofia Töyrä; Hu, Dan; Ekerljung, Linda; Malmhäll, Carina; Weiner, Howard L.; Lundbäck, Bo; Bokarewa, Maria I. (2017) Survivin controls biogenesis of microRNA in smokers: A link to pathogenesis of rheumatoid arthritis. En: Biochimica et Biophysica Acta (BBA). Vol. 1863; No. 3; pp. 663 - 673; Disponible en: 10.1016/j.bbadis.2016.11.033.Erlandsson, Malin C.; Turkkila, Minna; Siljehult, Filip; Pullerits, Rille; Eriksson, Catharina; Rantapää-Dahlqvist, Solbritt; Bokarewa, Maria I. (2018) Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden. En: Seminars in Arthritis and Rheumatism. Vol. 47; No. 6; pp. 778 - 785; Disponible en: 10.1016/j.semarthrit.2017.10.020.Baran, Marcin; Möllers, Linda Nilsson; Andersson, Sofia; Jonsson, Ing‐Marie; Ekwall, Anna‐Karin Hultgård; Bjersing, Jan; Tarkowski, Andrej; Bokarewa, Maria (2009) Survivin is an essential mediator of arthritis interacting with urokinase signalling. En: Journal of Cellular and Molecular Medicine. Vol. 13; No. 9b; pp. 3797 - 3808; Disponible en: 10.1111/j.1582-4934.2009.00721.x.Jenko, Barbara; Praprotnik, Sonja; Čučnik, Saša; Rotar, Žiga; Tomšič, Matija; Dolžan, Vita (2016) Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients. En: Pharmacogenomics. Vol. 17; No. 1; pp. 45 - 9; Disponible en: 10.2217/pgs.15.147.Ma, Sha; Wang, Jing; Lin, Jun; Jin, Song; He, Fang; Mei, Jian; Zhang, Hong; Wang, Shuya; Li, Qin (2021) Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the NOTCH pathway. En: International Journal of Rheumatic Diseases. Vol. 24; No. 7; pp. 922 - 929; Disponible en: 10.1111/1756-185X.14150.Ebrahimiyan, Hamidreza; Rezaei, Nima; Vojdanian, Mahdi; Aslani, Saeed; Jamshidi, Ahmadreza; Mahmoudi, Mahdi (2019) microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. En: International Journal of Rheumatic Diseases. Vol. 22; No. 6; pp. 1107 - 1114; Disponible en: 10.1111/1756-185X.13520.Chen, Danna; Liu, Dongdong; Liu, Dan; He, Min; Peng, Anping; Xu, Jiarui; Lin, Li; Luo, Fudong; Chen, Lin; Huang, Xianzhang; Zhuang, Junhua; Xu, Jianhua (2017) Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing. En: Scientific Reports. Vol. 7; No. 1; pp. 367 - 367; Disponible en: 10.1038/s41598-017-00517-w.YANG, SHUZHONG; YANG, YOUGENG (2015) Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis. En: Molecular Medicine Reports. Vol. 12; No. 2; pp. 2395 - 2401; Disponible en: 10.3892/mmr.2015.3642.Mokuda, Sho; Miyazaki, Tatsuhiko; Ito, Yuki; Yamasaki, Satoshi; Inoue, Hiroko; Guo, Yun; Kong, Weng-Sheng; Kanno, Masamoto; Takasugi, Kiyoshi; Sugiyama, Eiji; Masumoto, Junya (2015) The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. En: Scientific Reports. Vol. 5; No. 1; pp. 9795 - 9795; Disponible en: 10.1038/srep09795.Mera, Simona; Magnusson, Mattias; Tarkowski, Andrej; Bokarewa, Maria (2008) Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. En: Journal of Leukocyte Biology. Vol. 83; No. 1; pp. 149 - 155; Disponible en: 10.1189/jlb.0507287.Long, Xian Ming (2014) Expression of Survivin in Patients With Refractory Rheumatoid Arthritis in a Chinese Population. En: Archives of Rheumatology. Vol. 29; No. 2; pp. 81 - 87; Disponible en: 10.5606/ArchRheumatol.2014.3841.Liu, Yun; Aryee, Martin J; Padyukov, Leonid; Fallin, M Daniele; Hesselberg, Espen; Runarsson, Arni; Reinius, Lovisa; Acevedo, Nathalie; Taub, Margaret; Ronninger, Marcus; Shchetynsky, Klementy; Scheynius, Annika; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Ekström, Tomas J; Feinberg, Andrew P (2013) Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. En: Nature Biotechnology. Vol. 31; No. 2; pp. 142 - 147; Disponible en: 10.1038/nbt.2487.Klein, Kerstin; Gay, Steffen (2015) Epigenetics in rheumatoid arthritis. En: Current opinion in rheumatology. Vol. 27; No. 1; pp. 76 - 82; Disponible en: 10.1097/BOR.0000000000000128.Vandeputte, Doris; Kathagen, Gunter; D’hoe, Kevin; Vieira-Silva, Sara; Valles-Colomer, Mireia; Sabino, João; Wang, Jun; Tito, Raul Y.; De Commer, Lindsey; Darzi, Youssef; Vermeire, Séverine; Falony, Gwen; Raes, Jeroen (2017) Quantitative microbiome profiling links gut community variation to microbial load. En: Nature. Vol. 551; No. 7681; pp. 507 - 511; Disponible en: 10.1038/nature24460.Maeda, Yuichi; Takeda, Kiyoshi (2019) Host–microbiota interactions in rheumatoid arthritis. En: Experimental & Molecular Medicine. Vol. 51; No. 12; pp. 1 - 6; Disponible en: 10.1038/s12276-019-0283-6.Pimsen, Apiradee; Kao, Chi-Yin; Hsu, Sheng-Tzu; Shu, Bih-Ching (2022) The Effect of Advance Care Planning Intervention on Hospitalization Among Nursing Home Residents: A Systematic Review and Meta-Analysis. En: Journal of the American Medical Directors Association. Vol. 23; No. 9; pp. 1448 - 1460.e1; Disponible en: 10.1016/j.jamda.2022.07.017.Bansal, Nancy; Pasricha, Chirag; Kumari, Pratima; Jangra, Sarita; Kaur, Rupinder; Singh, Ravinder (2023) A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management. En: Autoimmunity Reviews. Vol. 22; No. 7; pp. 103337 - 103337; Disponible en: 10.1016/j.autrev.2023.103337.Giancane, Gabriella; Consolaro, Alessandro; Lanni, Stefano; Davì, Sergio; Schiappapietra, Benedetta; Ravelli, Angelo (2016) Juvenile Idiopathic Arthritis: Diagnosis and Treatment. En: Rheumatology and Therapy. Vol. 3; No. 2; pp. 187 - 207; Disponible en: 10.1007/s40744-016-0040-4.instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURArtritis reumatoideArtritis reumatoide sistémica juvenilArtritis Idiopática juvenilSurvivinaBiomarcadoresRheumatoid arthritisJuvenile Systemic Rheumatoid ArthritisJuvenile Idiopathic ArthritisSurvivinBiomarkersNiveles de survivina y su utilidad clínica en la artritis reumatoide/artritis idiopática juvenil: revisión sistemática de la literatura y meta-análisisSurvivin levels and its clinical utility in rheumatoid arthritis/juvenile idiopathic arthritis: systematic review of the literature and meta-analysisbachelorThesisTrabajo de gradoTrabajo de gradohttp://purl.org/coar/resource_type/c_7a1fEscuela de Medicina y Ciencias de la SaludBogotáORIGINALNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdfNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdfapplication/pdf1040640https://repository.urosario.edu.co/bitstreams/ce8f1bcf-62ce-4da7-95ee-49834a6d7776/downloadafae44c56de18a3c95484c7d36a3f8d6MD55Niveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.risNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.risapplication/x-research-info-systems66873https://repository.urosario.edu.co/bitstreams/c1d0ed03-476c-457a-941d-162786df24de/download617b5754a3e0f1fa52d58569bee1858fMD52LICENSElicense.txtlicense.txttext/plain1483https://repository.urosario.edu.co/bitstreams/7f9924f3-38e4-46c1-a6bf-9e0a1a47c052/downloadb2825df9f458e9d5d96ee8b7cd74fde6MD53CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8899https://repository.urosario.edu.co/bitstreams/d21242a7-e29e-43b5-957e-aee369f15204/download3b6ce8e9e36c89875e8cf39962fe8920MD54TEXTNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdf.txtNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdf.txtExtracted texttext/plain102071https://repository.urosario.edu.co/bitstreams/5d2972cc-6c52-4592-be3f-5e3f0c00a44d/download1fa4f1f0c377618f10b6410bd4b0b0dcMD56THUMBNAILNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdf.jpgNiveles_de_survivina_y_su_utilidad_clinica_en_la_artritis.pdf.jpgGenerated Thumbnailimage/jpeg2815https://repository.urosario.edu.co/bitstreams/1fe74377-6ba5-4ceb-b378-a84a07b54cdc/downloadb579d5c82d91572dcf7314cbc305e30eMD5710336/42989oai:repository.urosario.edu.co:10336/429892024-07-11 03:00:53.998http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttps://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.coRUwoTE9TKSBBVVRPUihFUyksIG1hbmlmaWVzdGEobWFuaWZlc3RhbW9zKSBxdWUgbGEgb2JyYSBvYmpldG8gZGUgbGEgcHJlc2VudGUgYXV0b3JpemFjacOzbiBlcyBvcmlnaW5hbCB5IGxhIHJlYWxpesOzIHNpbiB2aW9sYXIgbyB1c3VycGFyIGRlcmVjaG9zIGRlIGF1dG9yIGRlIHRlcmNlcm9zLCBwb3IgbG8gdGFudG8gbGEgb2JyYSBlcyBkZSBleGNsdXNpdmEgYXV0b3LDrWEgeSB0aWVuZSBsYSB0aXR1bGFyaWRhZCBzb2JyZSBsYSBtaXNtYS4KPGJyLz4KUEFSQUdSQUZPOiBFbiBjYXNvIGRlIHByZXNlbnRhcnNlIGN1YWxxdWllciByZWNsYW1hY2nDs24gbyBhY2Npw7NuIHBvciBwYXJ0ZSBkZSB1biB0ZXJjZXJvIGVuIGN1YW50byBhIGxvcyBkZXJlY2hvcyBkZSBhdXRvciBzb2JyZSBsYSBvYnJhIGVuIGN1ZXN0acOzbiwgRUwgQVVUT1IsIGFzdW1pcsOhIHRvZGEgbGEgcmVzcG9uc2FiaWxpZGFkLCB5IHNhbGRyw6EgZW4gZGVmZW5zYSBkZSBsb3MgZGVyZWNob3MgYXF1w60gYXV0b3JpemFkb3M7IHBhcmEgdG9kb3MgbG9zIGVmZWN0b3MgbGEgdW5pdmVyc2lkYWQgYWN0w7phIGNvbW8gdW4gdGVyY2VybyBkZSBidWVuYSBmZS4KPGhyLz4KRUwgQVVUT1IsIGF1dG9yaXphIGEgTEEgVU5JVkVSU0lEQUQgREVMIFJPU0FSSU8sICBwYXJhIHF1ZSBlbiBsb3MgdMOpcm1pbm9zIGVzdGFibGVjaWRvcyBlbiBsYSBMZXkgMjMgZGUgMTk4MiwgTGV5IDQ0IGRlIDE5OTMsIERlY2lzacOzbiBhbmRpbmEgMzUxIGRlIDE5OTMsIERlY3JldG8gNDYwIGRlIDE5OTUgeSBkZW3DoXMgbm9ybWFzIGdlbmVyYWxlcyBzb2JyZSBsYSBtYXRlcmlhLCAgdXRpbGljZSB5IHVzZSBsYSBvYnJhIG9iamV0byBkZSBsYSBwcmVzZW50ZSBhdXRvcml6YWNpw7NuLgoKLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0KClBPTElUSUNBIERFIFRSQVRBTUlFTlRPIERFIERBVE9TIFBFUlNPTkFMRVMuIERlY2xhcm8gcXVlIGF1dG9yaXpvIHByZXZpYSB5IGRlIGZvcm1hIGluZm9ybWFkYSBlbCB0cmF0YW1pZW50byBkZSBtaXMgZGF0b3MgcGVyc29uYWxlcyBwb3IgcGFydGUgZGUgTEEgVU5JVkVSU0lEQUQgREVMIFJPU0FSSU8gIHBhcmEgZmluZXMgYWNhZMOpbWljb3MgeSBlbiBhcGxpY2FjacOzbiBkZSBjb252ZW5pb3MgY29uIHRlcmNlcm9zIG8gc2VydmljaW9zIGNvbmV4b3MgY29uIGFjdGl2aWRhZGVzIHByb3BpYXMgZGUgbGEgYWNhZGVtaWEsIGNvbiBlc3RyaWN0byBjdW1wbGltaWVudG8gZGUgbG9zIHByaW5jaXBpb3MgZGUgbGV5LiBQYXJhIGVsIGNvcnJlY3RvIGVqZXJjaWNpbyBkZSBtaSBkZXJlY2hvIGRlIGhhYmVhcyBkYXRhICBjdWVudG8gY29uIGxhIGN1ZW50YSBkZSBjb3JyZW8gaGFiZWFzZGF0YUB1cm9zYXJpby5lZHUuY28sIGRvbmRlIHByZXZpYSBpZGVudGlmaWNhY2nDs24gIHBvZHLDqSBzb2xpY2l0YXIgbGEgY29uc3VsdGEsIGNvcnJlY2Npw7NuIHkgc3VwcmVzacOzbiBkZSBtaXMgZGF0b3MuCg==